Research programme: antibody therapeutics - Evive Biotech/Nona Biosciences
Latest Information Update: 21 Dec 2023
At a glance
- Originator Evive Biotech; Nona Biosciences
- Class Monoclonal antibodies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Unspecified